Table 2.

Patient characteristic table

Patient nr.	Age	T category	N category	M category	Gleason score	PSA (ng/ml) value at the time of admission of the study	Previous treatment (P, R, ADT, B)*
1	59	2C	0	0	3+3	1.07	P, R
2	60	3B	1	0	3+4	5.9	P
3	61	2B	0	0	2+3	0.851	P
4	49	2B	0	0	3+4	0.763	P, R
5	71	3B	0	0	3+3	0.24	P, R
6	61	2A	0	0	3+4	4	P
7	67	3	0	0	4+4	2	R, ADT
8	55	2C	0	0	3+4	0.475	P
9	62	2C	0	0	3+4	0.329	P
10	64	2C	0	0	3+4	1.076	P
11	54	2C	0	0	3+4	1.11	P
12	81	2	0	0	5+5	14.862	P
13	74	3B	0	0	3+3	8.447	P, ADT
14	56	2C	0	0	4+5	0.493	P
15	61	2C	0	0	3+4	0.283	P
16	64	3B	0	0	3+4	1.79	P, ADT
17	58	3B	0	0	4+3	2.82	P
18	68	2B	0	0	3+3	0.256	P
19	71	3B	0	0	4+5	0.591	P, R, ADT
20	66	2C	0	0	3+3	0.215	P
21	69	3A	0	0	4+4	3.413	R, ADT
22	71	2C	0	0	3+4	0.33	P, R
23	70	2C	0	0	3+4	0.49	P
24	62	2C	0	0	3+4	1.58	P
25	62	2C	0	0	4+3	0.217	P, ADT
26	71	2C	0	0	3+5	10.1	B, R, ADT
27	56	2C	0	0	3+3	1.37	P
28	54	3B	0	0	4+3	4.05	P, R, ADT
29	61	3B	0	0	3+4	0.908	P, R, ADT
30	56	3B	0	0	3+4	0.874	P
31	69	3B	0	0	4+4	5.29	P, ADT
32	65	3B	1	0	4+4	1.2	P

^*P - radical prostatectomy, R - radiation therapy, ADT - androgen deprivation therapy, B - brachytherapy.